Hepatitis C: all 2,356 studies
Page 19 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and RaltegravirCompletedNCT01253551Phase 1
- A Pilot Study of High-Dose, Intravenous Ascorbic Acid (Vitamin C) to Treat Hepatitis CTerminatedNCT01250743Not applicable
- A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1CompletedNCT01247194Phase 1
- TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and RaltegravirCompletedNCT01241773Phase 1
- Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infectionCompletedNCT01231685Phase 2
- Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1CompletedNCT01226771Phase 3
- Safety Study of Raltegravir in HIV/HCV Co-infected PatientsWithdrawnNCT01225705Phase 4
- A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01225380Phase 2
- TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese VolunteersCompletedNCT01224197Phase 1
- A Study of Danoprevir Boosted With Low Dose Ritonavir in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01220947Phase 2
- Differences in Evoked Intracellular Interferon Signaling Pathways Using Single Cell Phosphoprotein ProfilingCompletedNCT01217359Phase 1
- Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)CompletedNCT01211626Phase 1
- Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone MaintenanceCompletedNCT01210404Phase 1
- Acoustic Liver Biopsy in Normals and in Patients With Cirrhosis Using Endoscopic UltrasoundCompletedNCT01208311
- The Effect of HIV Tat Protein on HCV Replication in an In-vitro Model SystemCompletedNCT01206933
- TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and TenofovirCompletedNCT01205139Phase 1
- TMC647055HPC1001 - First-in-human Trial to Examine Safety, Tolerability and Pharmacokinetics (How the Drug is Absorbed Into the Bloodstream) of Increasing Single Oral Doses and of Increasing Repeated Oral Doses of TMC647055 in Healthy Volunteers and in Hepatitis C Virus Infected PatientsCompletedNCT01202825Phase 1
- Multiple Ascending Dose Study of Miravirsen in Treatment-Naïve Chronic Hepatitis C SubjectsCompletedNCT01200420Phase 2
- An Observational Study on The Impact of Insulin Resistance on Sustained Virological Response in Patients With Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)CompletedNCT01200225
- Study of the Impact of Nitazoxanide on Chronic Hepatitis PatientsCompletedNCT01197157Phase 2/3
- Immune Dysregulation in Hepatitis C Patients With or Without ArthritisStatus unknownNCT01195987
- Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.CompletedNCT01195181Phase 4
- A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis CCompletedNCT01194037Phase 1/2
- A Multiple Ascending Dose Study of GS 5885 in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis CCompletedNCT01193478Phase 1
- Ph IIA Study (SOC +/- NS5B)CompletedNCT01193361Phase 2
- A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1CompletedNCT01185860Phase 1
- Study of ABT-267 in Both Healthy Volunteers and Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCompletedNCT01181427Phase 1
- A Study on Safety, Tolerability and Pharmacokinetics of RO5303253 in Healthy Volunteers and Patients With Chronic Hepatitis C Genotype 1CompletedNCT01181024Phase 1
- Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.CompletedNCT01178996Phase 3
- Exploration of Chronic Hepatitis C Infection Receiving 24-week Interferon-α With Ribavirin TreatmentsStatus unknownNCT01178749
- Evaluating the Safety of ITX 5061 in Treatment-Naive Hepatitis C (HCV)-Infected AdultsCompletedNCT01165359Phase 1
- A Phase 1b, Single Center, Clinical Study to Investigate the Safety and Biological Responses to Baminercept in Patients With Chronic HCV Hepatitis.Status unknownNCT01164384Phase 1
- Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?CompletedNCT01159613
- Study the Relationship Between Obesity and Hepatitis C ReplicationWithdrawnNCT01157975Phase 2
- A Drug-Drug Interaction Study Evaluating the Combination of IDX320 and IDX184 in Healthy Participants (MK-6844-002)CompletedNCT01157104Phase 1
- Romiplostim in Treating Hepatitis C-Infected Patients With ThrombocytopeniaTerminatedNCT01153919Phase 2
- Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?Status unknownNCT01151397Not applicable
- Does Vitamin D Improves Sustained Virologic Response (SVR) in Genotype 2,3 Chronic Hepatitis C Patients?Status unknownNCT01146626Not applicable
- Study of VX-985 in Subjects With Chronic Hepatitis CCompletedNCT01144936Phase 1
- A Study of BMS-824393 in Combination With Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment Naive Subjects With Chronic Hepatitis C Virus Genotype IWithdrawnNCT01142700Phase 2
- Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis CCompletedNCT01140997Phase 2
- Pegaferon and Ribavirin for Hepatitis CCompletedNCT01137383Phase 3
- TMC435-TiDP16-C119 - A Study Comparing 2 New Capsule Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Respective Blood Levels of TMC435 Following Single Dose AdministrationCompletedNCT01134718Phase 1
- TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun LightCompletedNCT01124799Phase 1
- Brief Intervention for Drug Misuse in the Emergency DepartmentCompletedNCT01124591Phase 2
- A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis CCompletedNCT01121731Phase 1/2
- Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)CompletedNCT01121705Phase 3
- Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid PharmacotherapyCompletedNCT01120795Phase 4
- Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCVCompletedNCT01113814Not applicable
- Biliverdin Reductase A in Chronic Hepatitis C Virus InfectionCompletedNCT01112033
- Injecting Drug Use Community Intervention TrialStatus unknownNCT01108614Phase 3
- Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug UsersStatus unknownNCT01105611Phase 4
- Chronic Hepatitis C (CHC) - Genotype 3 Infection in CanadaTerminatedNCT01100749
- EXtended Therapy in Hepatitis C Genotype 3 Infected PatientsTerminatedNCT01095445Phase 3
- Study of a Novel Therapeutic Vaccine for Hepatitis C VirusCompletedNCT01094873Phase 1
- A Pilot Study of the Grapefruit Flavonoid Naringenin for HCV InfectionCompletedNCT01091077Phase 1
- TMC435-TiDP16-C112 - Interaction Trial With AntidepressantsCompletedNCT01090700Phase 1
- A Study of Single Doses of ABT-072 in Japanese Healthy Male AdultsCompletedNCT01081483Phase 1
- Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)CompletedNCT01081158Phase 1
- A Safety and Efficacy Study of the Combination of VX-222 and Telaprevir in Treatment-Naïve Subjects With Genotype 1 Chronic Hepatitis C Virus InfectionTerminatedNCT01080222Phase 2
- A Pilot Study to Examine the Role of Nitazoxanide to Prevent Recurrence of Hepatitis C After TransplantationCompletedNCT01074203Phase 1
- Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus InfectionCompletedNCT01072695Phase 2
- A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)CompletedNCT01070407Phase 1
- Drug Interaction Oral Contraceptive Pill (OCP)CompletedNCT01063023Phase 1
- Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) PatientsWithdrawnNCT01062659
- A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard TherapyCompletedNCT01058512Phase 2
- A Study of RO5024048 in Combination With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 1 or 4CompletedNCT01057667Phase 2
- PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)Status unknownNCT01056172Phase 4
- Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV PatientsCompletedNCT01055821Phase 2
- The Incidence of Occult Hepatitis C Virus Infection in Hemodialysed Patients With Liver Enzymes DisturbancesStatus unknownNCT01054664
- Safety and Efficacy Study in Hepatitis C Patients With PHN121TerminatedNCT01052090Phase 1/2
- An Anti-viral Combination Study With Japanese Hepatitis C Infection (HCV) SubjectCompletedNCT01051414Phase 2
- Notification of Donors With Positive Microbiology MarkersCompletedNCT01050881
- TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435CompletedNCT01046058Phase 1
- Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral TherapyCompletedNCT01045278Phase 4
- Pilot Study to Assess Gut Mucosal B Cells in Individuals With HCV and HIVTerminatedNCT01040039
- A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy AdultsCompletedNCT01038167Phase 1
- Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis CStatus unknownNCT01037621Phase 1
- Epidemiological Study to Evaluate the Management of Patients With Chronic Hepatitis C and Previous Treatment FailureCompletedNCT01033045
- Study of BMS-650032 With Peginterferon Alfa-2a Plus RibavirinCompletedNCT01030432Phase 2
- The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus RibavirinStatus unknownNCT01025765Phase 4
- Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)CompletedNCT01025596Phase 1/2
- Cell Bound Complement Activation Proteins as Markers of Liver InjuryWithdrawnNCT01025531
- Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in HCV Genotype 1 or 4 Patients Resistant to Bitherapy AloneStatus unknownNCT01025297Phase 1/2
- Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to BitherapyStatus unknownNCT01024894Phase 1/2
- Raltegravir in Patients With End Stage Liver Disease and in Transplant RecipientsCompletedNCT01022476Phase 1/2
- TMC435-TiDP16-C121: A Study Comparing 2 Tablet Formulations of TMC435 to an Established Capsule Formulation and Evaluating the Effect of Food on Blood Levels of TMC435CompletedNCT01022125Phase 1
- Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of CareCompletedNCT01012895Phase 2
- Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)CompletedNCT01011166Phase 2
- Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4CompletedNCT01010646Phase 2
- Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01008358Phase 2
- Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4CompletedNCT01006031Phase 2/3
- Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus InfectionStatus unknownNCT01001754Phase 2
- ADHEPTA Study: Adherence Questionnaire in Hepatitis CCompletedNCT00998621
- Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy SubjectsCompletedNCT00996879Phase 1
- Ribavirin Pre-treatment Followed by Combined Standard Therapy in Hepatitis C Virus (HCV) RecipientsCompletedNCT00993122Phase 4
- Blood Antioxidant Status in Chronic Hepatitis C Patients Before and After Antioxidant Supplementation: a Randomized Clinical TrialCompletedNCT00983164Not applicable
- Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected PatientsCompletedNCT00983060Phase 2
- Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072CompletedNCT00982826Phase 1
- Micro RNA-122 and the Clinical Course of Patients With Chronic Hepatitis CStatus unknownNCT00980161